Home/Filings/4/0001799191-22-000042
4//SEC Filing

Shah Mihir 4

Accession 0001799191-22-000042

CIK 0001799191other

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 5:35 PM ET

Size

7.5 KB

Accession

0001799191-22-000042

Insider Transaction Report

Form 4
Period: 2022-11-17
Shah Mihir
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-11-17+18,60250,723 total
  • Award

    Non-Qualified Stock Option (right to buy)

    2022-11-17+94,41894,418 total
    Exercise: $1.87Exp: 2032-11-17Common Stock (94,418 underlying)
Footnotes (2)
  • [F1]Represents RSUs with 1/4th of the RSUs vesting on the anniversary of November 17, 2022 (the Vesting Commencement Date), with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
  • [F2]The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

Issuer

Oncology Institute, Inc.

CIK 0001799191

Entity typeother

Related Parties

1
  • filerCIK 0001676960

Filing Metadata

Form type
4
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 5:35 PM ET
Size
7.5 KB